Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$29.52 -0.32 (-1.07%)
At close: Sep 29, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) Common Equity (2013 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) posted Common Equity of $3.81 billion for the quarter ended Mar 31, 2026, up 31.8% from $2.89 billion a year earlier and up 1.1% from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) Common Equity (2013 - 2026) Analysis & Trends

As of Dec 31, 2025, Lakefront Biotherapeutics' Common Equity came in at $3.66 billion, up 16.6% from the prior year.

  • Annual Common Equity has increased for three consecutive years, with a five-year compound annual growth rate of 3.7% (years ended Dec 2020 to Dec 2025).
  • In prior years, Lakefront Biotherapeutics' Common Equity was $3.14 billion in the year ended Dec 31, 2024 (+4.2%), $3.01 billion in the year ended Dec 31, 2023 (+13.0%), $2.66 billion in the year ended Dec 31, 2022 (-14.9%) and $3.13 billion in the year ended Dec 31, 2021 (+2.6%).
  • The figure for the quarter ended Mar 31, 2026 stands as the highest quarterly Common Equity since the quarter ended Jun 30, 2018.
  • On a year-over-year basis, Common Equity increased in four of the last six quarters, with growth averaging 8.2%.
  • The strongest year-over-year quarter for Common Equity in the past five years was the quarter ended Mar 31, 2026, with growth of 31.8%; the weakest was the quarter ended Dec 31, 2022, with a decline of 14.8%.
  • According to Business Quant data, Common Equity for the three prior quarters was $3.77 billion (quarter ended Dec 31, 2025), $2.86 billion (quarter ended Sep 30, 2025) and $2.99 billion (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Lakefront Biotherapeutics 1.97 Bn 1.97 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.81 Bn
Dec 31, 2025 3.77 Bn
Sep 30, 2025 2.86 Bn
Jun 30, 2025 2.99 Bn
Mar 31, 2025 2.89 Bn
Dec 31, 2024 3.10 Bn
Sep 30, 2024 3.14 Bn
Mar 31, 2024 3.15 Bn
Dec 31, 2023 3.01 Bn
Sep 30, 2023 2.85 Bn
Mar 31, 2023 2.75 Bn
Dec 31, 2022 2.58 Bn
Mar 31, 2022 2.97 Bn
Dec 31, 2021 3.02 Bn
Jun 30, 2021 3.21 Bn
Dec 31, 2020 3.18 Bn
Jun 30, 2020 3.05 Bn
Mar 31, 2020 3.14 Bn
Dec 31, 2019 3.18 Bn
Sep 30, 2019 2.82 Bn
API Access

Lakefront Biotherapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=LKFT&period=max&api_key=YOUR_API_KEY